Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Corso

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
JAMA Oncology|October 14, 2016
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell CarcinomaZain A Husain, Tiange Chen, Christopher D Corso, et al.
Neuro-Oncology Practice|August 9, 2020
The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymomaRoshan S Prabhu, Christopher D Corso, Matthew C Ward, et al.
Gynecologic Oncology|May 7, 2016
Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data BaseNataniel H Lester-Coll, Henry S Park, Charles E Rutter, et al.
Cancer|May 13, 2016
Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiformeAdam J Kole, Henry S Park, Debra N Yeboa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2015
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerChristopher D Corso, Charles E Rutter, Henry S Park, et al.
Nature Genetics|July 18, 2018
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repairParker L Sulkowski, Ranjini K Sundaram, Sebastian Oeck, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
JAMA Oncology|October 14, 2016
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell CarcinomaZain A Husain, Tiange Chen, Christopher D Corso, et al.
Neuro-Oncology Practice|August 9, 2020
The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymomaRoshan S Prabhu, Christopher D Corso, Matthew C Ward, et al.
Gynecologic Oncology|May 7, 2016
Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data BaseNataniel H Lester-Coll, Henry S Park, Charles E Rutter, et al.
Cancer|May 13, 2016
Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiformeAdam J Kole, Henry S Park, Debra N Yeboa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2015
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerChristopher D Corso, Charles E Rutter, Henry S Park, et al.
Nature Genetics|July 18, 2018
Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repairParker L Sulkowski, Ranjini K Sundaram, Sebastian Oeck, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Pageof 4